Anxiety Linked to Gut Disease Trajectories

Longitudinal electronic health record data are used to examine temporal relationships between psychiatric and gastrointestinal diagnoses.

Category	Detail
Condition	Anxiety Disorders, Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD)
Key Mechanisms	Bidirectional association between anxiety and gastrointestinal conditions, particularly IBS.
Target Population	Adult patients aged 18 years or older with anxiety disorders, IBS, or IBD.
Care Setting	Retrospective cohort study utilizing electronic health records.

Anxiety is associated with a twofold increase in the likelihood of developing IBS.
6.6% of patients with IBS developed anxiety compared to 3.0% of controls.
Anxiety precedes IBD slightly more often than in matched controls, but the incidence is low.
Associations between anxiety and IBD are weaker compared to those with IBS.
Study limitations include potential misclassification and residual confounding.

Use International Classification of Diseases, Tenth Revision codes for diagnosis.

Consider the bidirectional relationship when treating patients with anxiety and gastrointestinal disorders.

Be aware of the limitations in causal inference due to the observational study design.

Adults with anxiety disorders, IBS, or IBD.

Avoid confounding factors such as prior psychiatric disorders or GI diseases when assessing treatment outcomes.

Implement propensity score matching to balance exposure and control cohorts.
Acknowledge the limitations of retrospective studies in clinical decision-making.
Consider the impact of unmeasured factors like socioeconomic status and diet on patient outcomes.

Clinical Scorecard: Anxiety Linked to Gut Disease Trajectories